medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2024, Número 4

<< Anterior Siguiente >>

Cir Card Mex 2024; 9 (4)


Reparación de la válvula mitral borde a borde con catéter: una técnica sustitutiva que imita de forma imperfecta. La cruda y fría verdad a partir de observaciones basadas en datos

García-Villarreal OA

Idioma: Ingles.
Referencias bibliográficas: 53
Paginas: 139-146
Archivo PDF: 567.24 Kb.


RESUMEN

En los últimos años, el procedimiento de reparación de la válvula mitral de borde a borde mediante catéter ha ganado popularidad como una tecnología pionera en cardiología intervencionista estructural. Este enfoque innovador tiene sus raíces en la técnica quirúrgica de reparación de la válvula mitral, pero carece de un anillo de anuloplastia, una condición sine qua non para la reparación quirúrgica de la válvula mitral. Por lo tanto, la reparación de la válvula mitral de borde a borde mediante catéter muestra una eficacia incierta a largo plazo en el tratamiento de la insuficiencia mitral. De tal manera que es crucial considerar cuidadosamente las posibles consecuencias a largo plazo de una técnica imperfecta, que abarcan la supervivencia del paciente, la calidad de vida y las rehospitalizaciones no planificadas por tasas de insuficiencia cardíaca, así como la probabilidad de recurrencia de la insuficiencia mitral. Desde una perspectiva teórica, la integración de la reparación transcatéter borde a borde con la implantación percutánea de un anillo de anuloplastia podrían mitigar potencialmente el problema de la durabilidad a largo plazo. Debido a la complejidad del tema de la insuficiencia mitral funcional, este artículo se enfocará exclusivamente en la insuficiencia mitral degenerativa.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932.

  2. Vahanian A, Beyersdorf F, Praz F, et al; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. doi: 10.1093/eurheartj/ehab395.

  3. Carpentier A. La valvuloplastie reconstructive. Une nouvelle technique de valvuloplastie mitrale [Reconstructive valvuloplasty. A new technique of mitral valvuloplasty]. Presse Med 1969;77(7):251-3. [article in French].

  4. Carpentier A, Deloche A, Dauptain J, et al. A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg. 1971;61(1):1-13.

  5. Carpentier A, Relland J, Deloche A, et al. Conservative management of the prolapsed mitral valve. Ann Thorac Surg. 1978;26(4):294-302. doi: 10.1016/s0003-4975(10)62895-0.

  6. Carpentier A, Chauvaud S, Fabiani JN, et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg. 1980;79(3):338-348.

  7. Carpentier A. Cardiac valve surgery--the "French correction". J Thorac Cardiovasc Surg. 1983;86(3):323-337.

  8. Carpentier A, Adams D, Filsoufi F. Carpentier's reconstructive valve surgery. from valve analysis to valve reconstruction. Editorial Saunders (W.B.) Co Ltd. Elsevier. 2010. ISBN 9780721691688.

  9. Alfieri O, De Bonis M, La Canna G. (Eds.). Edge-to-Edge Mitral Repair. From a surgical to a percutaneous approach. Springer International Publishing Switzerland 2015. Electronic version. ISBN 978-3-319-19893-4 (eBook).

  10. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 1998;116(5):734-743. doi: 10.1016/S0022-5223(98)00450-4.

  11. Gillinov AM, Cosgrove DM. Mitral valve repair for degenerative disease. J Heart Valve Dis. 2002;11 Suppl 1:S15-20.

  12. David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. 2013;127(14):1485-1492. doi: 10.1161/CIRCULATIONAHA.112.000699.

  13. David TE. Durability of mitral valve repair for mitral regurgitation due to degenerative mitral valve disease. Ann Cardiothorac Surg. 2015;4(5):417-421. doi: 10.3978/j.issn.2225-319X.2015.08.07.

  14. Suri RM, Clavel MA, Schaff HV, et al. Effect of recurrent mitral regurgitation following degenerative mitral valve repair: long-term analysis of competing outcomes. J Am Coll Cardiol. 2016;67(5):488-498. doi: 10.1016/j.jacc.2015.10.098.

  15. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122(4):674-681. doi: 10.1067/mtc.2001.117277.

  16. De Bonis M, Lapenna E, Taramasso M, La Canna G, Buzzatti N, Pappalardo F, Alfieri O. Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: up to 21 years of clinical and echocardiographic results. J Thorac Cardiovasc Surg. 2014;148(5):2027-2032. doi: 10.1016/j.jtcvs.2014.03.041.

  17. De Bonis M, Lapenna E, Maisano F, et al. Long-term results (≤ 18 years) of the edge-to-edge mitral valve repair without annuloplasty in degenerative mitral regurgitation: implications for the percutaneous approach. Circulation. 2014;130(11 Suppl 1):S19-24. doi: 10.1161/CIRCULATIONAHA.113.007885.

  18. De Bonis M, Lapenna E, Pozzoli A, Giacomini A, Alfieri O. Edge-to-edge surgical mitral valve repair in the era of MitraClip: what if the annuloplasty ring is missed? Curr Opin Cardiol. 2015;30(2):155-160. doi: 10.1097/HCO.0000000000000148.

  19. Del Forno B, Castiglioni A, Sala A, et al. Mitral valve annuloplasty. Multimed Man Cardiothorac Surg. 2017;2017. doi: 10.1510/mmcts.2017.016.

  20. Buzzatti N, De Bonis M, Denti P, et al. What is a "good" result after transcatheter mitral repair? Impact of 2+ residual mitral regurgitation. J Thorac Cardiovasc Surg. 2016;151(1):88-96. doi: 10.1016/j.jtcvs.2015.09.099.

  21. Buzzatti N, Denti P, Scarfò IS, et al. Mid-term outcomes (up to 5 years) of percutaneous edge-to-edge mitral repair in the real-world according to regurgitation mechanism: a single-center experience. Catheter Cardiovasc Interv. 2019;94(3):427-435. doi: 10.1002/ccd.28029.

  22. Sugiura A, Kavsur R, Spieker M, et al. Recurrent mitral regurgitation after mitraclip: predictive factors, morphology, and clinical implication. Circ Cardiovasc Interv. 2022;15(3):e010895. doi: 10.1161/CIRCINTERVENTIONS.121.010895.

  23. Kubo S, Yamamoto M, Saji M, et al; OCEAN-Mitral Investigators. One-year outcomes and their relationship to residual mitral regurgitation after transcatheter edge-to-edge repair with MitraClip device: insights from the OCEAN-Mitral registry. J Am Heart Assoc. 2023;12(20):e030747. doi: 10.1161/JAHA.123.030747.

  24. Feldman T, Kar S, Elmariah S, et al; EVEREST II Investigators. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844-2854. doi: 10.1016/j.jacc.2015.10.018.

  25. Oztürk C, Friederich M, Werner N, Nickenig G, Hammerstingl C, Schueler R. Single-center five-year outcomes after interventional edge-to-edge repair of the mitral valve. Cardiol J. 2021;28(2):215-222. doi: 10.5603/CJ.a2019.0071.

  26. Adamo M, Grasso C, Capodanno D, et al. Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry. Am Heart J. 2019;217:32-41. doi: 10.1016/j.ahj.2019.06.015.

  27. Kar S, Feldman T, Qasim A, et al. Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients. Heart. 2019;105(21):1622-1628. doi: 10.1136/heartjnl-2017-312605.

  28. Sürder D, Klersy C, Corti R, et al. Impact of mitral regurgitation aetiology on MitraClip outcomes: the MitraSwiss registry. EuroIntervention. 2020;16(2):e112-e120. doi: 10.4244/EIJ-D-19-00718.

  29. Stone GW, Abraham WT, Lindenfeld J, et al. Five-year follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med. 2023;388(22):2037-2048. doi: 10.1056/NEJMoa2300213.

  30. Mack M, Carroll JD, Thourani V, et al. Transcatheter mitral valve therapy in the united states: a report from the STS/ACC TVT registry. Ann Thorac Surg. 2022;113(1):337-365. doi: 10.1016/j.athoracsur.2021.07.030.

  31. Reichart D, Kalbacher D, Rübsamen N, et al. The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitation. Eur J Heart Fail. 2020;22(10):1840-1848. doi: 10.1002/ejhf.1774.

  32. Adamo M, Pagnesi M, Popolo Rubbio A, et al. Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation. Catheter Cardiovasc Interv. 2022;99(5):1626-1635. doi: 10.1002/ccd.30062.

  33. Bedogni F, Popolo Rubbio A, Grasso C, et al. Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO): impact of valve disease aetiology and residual mitral regurgitation after MitraClip implantation. Eur J Heart Fail. 2021;(8):1364-1376. doi: 10.1002/ejhf.2159.

  34. De Felice F, Paolucci L, Musto C, et al. Postprocedural trans-mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair. Catheter Cardiovasc Interv. 2023;102(2):310-317. doi: 10.1002/ccd.30698.

  35. Stone GW, Adams DH, Abraham WT, et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol. 2015;66(3):308-321.

  36. Neuss M, Schau T, Isotani A, Pilz M, Schöpp M, Butter C. Elevated mitral valve pressure gradient after mitraclip implantation deteriorates long-term outcome in patients with severe mitral regurgitation and severe heart failure. JACC Cardiovasc Interv. 2017;10(9):931-939. doi: 10.1016/j.jcin.2016.12.280.

  37. Ludwig S, Koell B, Weimann J, et al; PRIME-MR Investigators. Impact of intraprocedural mitral regurgitation and gradient following transcatheter edge-to-edge repair for primary mitral regurgitation. JACC Cardiovasc Interv. 2024;17(13):1559-1573. doi: 10.1016/j.jcin.2024.05.018.

  38. El Shaer A, Chavez Ponce A, Mazur P, et al. Mitral valve surgery for persistent or recurrent mitral regurgitation after transcatheter edge-to-edge repair is associated with improved survival. J Am Heart Assoc. 2022;11(20):e026236. doi: 10.1161/JAHA.122.026236.

  39. Sugiura A, Weber M, Tabata N, et al. Prognostic impact of redo transcatheter mitral valve repair for recurrent mitral regurgitation. Am J Cardiol. 2020;130:123-129. doi: 10.1016/j.amjcard.2020.06.025.

  40. Kaneko T, Newell PC, Nisivaco S, et al. Incidence, characteristics, and outcomes of reintervention after mitral transcatheter edge-to-edge repair. J Thorac Cardiovasc Surg. 2024;167(1):143-154.e6. doi: 10.1016/j.jtcvs.2022.02.060.

  41. Kaneko T, Hirji S, Zaid S, et al.; CUTTING-EDGE Investigators. Mitral valve surgery after transcatheter edge-to-edge repair: mid-term outcomes from the CUTTING-EDGE International Registry. JACC Cardiovasc Interv. 2021 Sep 27;14(18):2010-2021. doi: 10.1016/j.jcin.2021.07.029.

  42. Zaid S, Avvedimento M, Vitanova K, et al. ; CUTTING-EDGE Investigators. Impact of mitral regurgitation etiology on mitral surgery after transcatheter edge-to-edge repair: from the cutting-EDGE Registry. JACC Cardiovasc Interv. 2023;16(10):1176-1188. doi: 10.1016/j.jcin.2023.02.029.

  43. Chikwe J, O'Gara P, Fremes S, et al. Mitral surgery after transcatheter edge-to-edge repair: society of thoracic surgeons database analysis. J Am Coll Cardiol. 2021;78(1):1-9. doi: 10.1016/j.jacc.2021.04.062.

  44. Verma S, Latter DA, Bonow RO. Failed mitral TEER: are there lessons for decision making? J Am Coll Cardiol. 2021;78(1):10-13. doi: 10.1016/j.jacc.2021.04.086.

  45. Rogers JH, Bolling SF. Transseptal direct complete annuloplasty: early experience. Ann Cardiothorac Surg. 2021;10(1):57-65. doi: 10.21037/acs-2020-mv-11.

  46. Weber M, Oztürk C, Taramasso M, et al. Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation. EuroIntervention. 2019;15(10):912-918. doi: 10.4244/EIJ-D-19-00468.

  47. Rogers JH, Boyd WD, Smith TW, Bolling SF. Transcatheter mitral valve direct annuloplasty with the millipede IRIS ring. Interv Cardiol Clin. 2019;8(3):261-267. doi: 10.1016/j.iccl.2019.02.001.

  48. Melica B, Braga P, Ribeiro J, et al. Transseptal mitral annuloplasty with the AMEND system: first-in-human experience. JACC Cardiovasc Interv. 2022;15(1):e3-e5. doi: 10.1016/j.jcin.2021.09.029. Transseptal direct complete annuloplasty: early experience.

  49. Young MN, Kearing S, Albaghdadi MA, Latib A, Iribarne A. Trends in transcatheter vs surgical mitral valve repair among medicare beneficiaries, 2012 to 2019. JAMA Cardiol. 2022;7(7):770-772. doi: 10.1001/jamacardio.2022.0775.

  50. Shah AM, Almomani AA, Sako EY, Hui DS. Surgical and transcatheter mitral valve therapy: medicare utilization and reimbursement. Ann Thorac Surg. 2024;118(1):164-171. doi: 10.1016/j.athoracsur.2023.09.014.

  51. Kumar K, Simpson TF, Golwala H, et al. Mitral valve transcatheter edge-to-edge repair volumes and trends. J Interv Cardiol. 2023;2023:6617035. doi: 10.1155/2023/6617035.

  52. Chikwe J, Chen Q, Bowdish ME, et al. Surgery and transcatheter intervention for degenerative mitral regurgitation in the United States. J Thorac Cardiovasc Surg. 2024:S0022-5223(24)00027-8. doi: 10.1016/j.jtcvs.2024.01.014.

  53. García-Villarreal OA. Expanding transcatheter edge-to-edge mitral valve repair indications: a word of caution. JACC Case Rep. 2022;4(19):1324. doi: 10.1016/j.jaccas.2022.06.027.




2020     |     www.medigraphic.com